Conditions

Xerostomia

Evidence: Medium Conditions Reading time: approx. 5 min. Reviewed: 08.08.2026 · KEERN Editorial Team

Xerostomia is the subjective sensation of a dry mouth. It is distinct from hyposalivation, the objectively measurable reduction in salivary flow rate; the two can occur together but do not always. The most common cause is medication. Reduced or altered saliva increases the risk of caries and mucosal discomfort.

Related terms:SalivaGingivitisCariesFluoridepHHalitosis

Definition

Xerostomia is the subjective feeling of dry mouth. It is distinct from hyposalivation, the objectively measurable reduction in salivary flow rate. The two can occur together, but not always: some people feel dry with a normal flow rate, while others have a substantially reduced flow rate without noticing it.

Dry mouth is not a disease in its own right. It is a symptom with many possible causes, ranging from medication to insufficient fluid intake to systemic conditions.

In short

Saliva does much more than keep the mouth moist. It continuously helps protect teeth, oral tissues, and the balance of the oral microbiome.

Saliva buffers acids, supports remineralization, and flushes out food debris. When this function is partially lost, the risk of caries, erosion, and mucosal discomfort increases. The most common cause is medication; targeted measures can often ease the symptoms.

Common misconception

Dry mouth is often assumed to be a normal part of getting older. It is not, at least not directly. What actually drives the association with age is usually polypharmacy, taking several medications at once, which becomes more common later in life. A 2025 primary care study found that polypharmacy combined with age over 71 was associated with nearly ten times higher odds of a xerostomia diagnosis, compared with patients taking no medication. Age itself is a marker for this pattern, not an independent cause.

Causes

  • Medications: by far the most common cause. Numerous drug classes are linked to dry mouth, including certain antidepressants, antihistamines, blood pressure medications, and diuretics
  • Radiation therapy to the head and neck, which can damage salivary gland tissue
  • Autoimmune conditions such as Sjögren's syndrome
  • Insufficient fluid intake, mouth breathing (including at night), and uncontrolled diabetes
  • Older age, usually in connection with taking multiple medications rather than as an independent cause

Effects on oral health

Reduced or altered saliva flow can increase the risk of caries and erosive tooth wear, even with careful oral hygiene. Dry mucosa, altered taste, difficulty swallowing or speaking, and a higher susceptibility to fungal infections (oral candidiasis) can also occur. For denture wearers, insufficient saliva can additionally affect how well dentures stay in place.

What may help

  • Drinking enough water, spread across the day in small amounts
  • Sugar-free gum or lozenges to stimulate saliva flow
  • Saliva substitute products, which can offer short-term relief for pronounced dryness
  • Avoiding alcohol-containing mouthwashes and other strongly drying products
  • If medication is suspected as the cause: raise the issue at a medical or dental visit. Never stop or change a prescribed medication without discussing it with the prescribing healthcare professional

When to see a dentist

A dental evaluation is worthwhile for persistent dry mouth, for frequent new caries lesions despite unchanged oral hygiene, or for burning or pain in the oral mucosa. Persistent dry mouth is not a minor discomfort; it is a risk factor worth taking seriously.

Key takeaways

  • Xerostomia (a felt sensation) and hyposalivation (a measurable reduction) are not the same thing
  • Medications are by far the most common cause
  • The link to older age mostly reflects polypharmacy, not aging itself
  • Reduced saliva flow raises the risk of caries, erosion, and mucosal discomfort
  • Water, chewing, and saliva substitutes may help short-term
  • Persistent symptoms are worth a dental or medical evaluation

Frequently Asked Questions

Is dry mouth the same as hyposalivation?

No. Xerostomia is the subjective feeling of dryness; hyposalivation is the objectively measurable reduction in saliva flow rate. Both can occur together, but not always: some people feel dry with a normal flow rate, others have a reduced flow rate without noticing.

Is dry mouth dangerous?

It can meaningfully affect oral health, because important protective functions of saliva are reduced. The risk of caries, erosion, and mucosal inflammation can increase noticeably, even with careful oral hygiene.

Is dry mouth just a normal part of aging?

Not directly. The connection to age largely reflects polypharmacy, taking multiple medications, which becomes more common later in life. A 2025 study found polypharmacy combined with age over 71 associated with nearly ten times higher odds of a xerostomia diagnosis, compared with patients on no medication.

What are typical triggers?

Most commonly medications; also mouth breathing, insufficient fluid intake, head and neck radiation therapy, or autoimmune conditions such as Sjögren's syndrome.

What helps in the short term?

Drinking enough water, sugar-free gum to stimulate saliva flow, and saliva substitute products where needed. The underlying cause should still be identified.

Can medications really cause dry mouth?

Yes, and quite commonly: numerous drug classes are associated with it. Never stop or change a prescribed medication without discussing it with the prescribing healthcare professional. Raise the issue at a medical or dental visit; there are often ways to ease the symptoms.

KEERN Perspective

Xerostomia shows clearly why oral health cannot be reduced to brushing technique alone. When a physiological protective function, here, saliva, is partially lost, the entire risk profile changes, regardless of how carefully someone brushes.

The underlying cause of persistent dry mouth belongs with a doctor or dentist. Adapted oral care can ease symptoms, but it does not replace identifying and addressing the cause.

Professional perspective

Clinical relevance

  • Caries risk diagnostics in reduced salivary flow
  • Medication history as a first diagnostic step
  • Care coordination for head and neck radiotherapy and Sjögren's syndrome
  • Individualized prevention in geriatric and polymedicated patients

Diagnosis

Sialometry distinguishes resting flow rate from stimulated flow rate. Commonly cited reference thresholds for hyposalivation are an unstimulated flow rate below 0.1 ml/min and a stimulated flow rate below 0.7 ml/min; these thresholds are conventions rather than absolute limits. Xerostomia without measurable hyposalivation occurs and should not be dismissed as trivial. Conversely, measurable hyposalivation can exist without subjective complaints, with unchanged clinical risk.

Etiology overview

Medications are the most common cause of reduced saliva production; several hundred substances are associated with xerostomia, including anticholinergics, tricyclic antidepressants, antihistamines, antihypertensives, and diuretics. The effect is amplified by polypharmacy. Other causes include head and neck radiation (dose-dependent salivary gland damage), Sjögren's syndrome and other autoimmune conditions, uncontrolled diabetes mellitus, dehydration, and habitual mouth breathing.

Clinical implications

A 2025 Swedish primary care register study found that polypharmacy (five or more concurrent medications) combined with age over 71 was associated with 9.68 times higher odds of a xerostomia diagnosis, compared with patients on no medication (p < 0.0001). Diagnosed prevalence was lowest in patients aged 18 to 35 (9.56 percent) and highest in those over 71 (41.49 percent), with women diagnosed considerably more often than men. The study's overall register-based diagnosis prevalence (0.23 percent) was far lower than self-reported prevalence figures reported in other populations, consistent with substantial underdiagnosis of xerostomia in routine primary care.

Management

Management includes, where possible, identifying and addressing the underlying cause, symptomatic measures to stimulate salivary flow (sugar-free chewing gum, with caution regarding acidic stimuli in patients at elevated erosion risk), and saliva substitute products for pronounced hyposalivation. Given the elevated caries risk, intensified caries prevention, often including professionally recommended topical fluoride according to individual caries risk, should be considered; this also includes more frequent recall intervals.

Guideline reference

No dedicated German AWMF guideline currently exists for xerostomia or hyposalivation specifically. The German S2k guideline on dental care for geriatric patients (AWMF, DGAZ/DGZMK) addresses dry mouth as a common comorbidity in older, often polymedicated patients. A separate German S2k guideline exists for the reverse condition, hypersalivation, which can serve as a point of comparison for how the two conditions are approached in guideline terms.

Evidence summary

What current evidence supports

  • Xerostomia (subjective dryness) and hyposalivation (measurable flow reduction) are internationally recognized as distinct, though related, phenomena
  • Medications are the best-documented cause of reduced salivary flow, with the effect amplified by polypharmacy
  • Polypharmacy combined with older age is associated with substantially higher odds of a xerostomia diagnosis than age alone
  • Reference thresholds of approximately 0.1 ml/min (unstimulated) and 0.7 ml/min (stimulated) are widely used internationally to define hyposalivation

Why this matters

Because the apparent link between xerostomia and aging is largely explained by polypharmacy, treating dry mouth as an inevitable consequence of getting older risks missing a modifiable factor: a medication review. Recognizing the distinction between xerostomia and hyposalivation also keeps care proportionate, since either can occur without the other, and both carry clinical relevance.

What remains uncertain

  • How much of the gap between register-based and self-reported prevalence figures reflects underreporting by patients versus underrecognition in primary care
  • The precise individual contribution of specific medications versus overall medication burden in polypharmacy-associated xerostomia
  • How reliably single-timepoint sialometry reflects an individual's typical salivary function over time

Villa, Connell, Abati (2015): Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management, 11, 45-51. Narrative review establishing widely cited reference values for normal and reduced salivary flow rates.

Kapourani, Kontogiannopoulos, Manioudaki, et al. (2022): A review on xerostomia and its various management strategies. Polymers, 14(5), 850. Narrative review focused on pharmaceutical formulations for saliva substitution.

Rughwani, Miao Jonasson, Marklund, et al. (2025): Xerostomia in primary care: a register-based study of prevalence, medication categories, and associated risk factors. Frontiers in Oral Health, 6, 1684568. Register-based study from Sweden quantifying the association between polypharmacy, age, and xerostomia diagnosis.

Sources

📚 Villa A, Connell CL, Abati S (2015): Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management, 11, 45-51.
📚 Kapourani A, Kontogiannopoulos KN, Manioudaki AE, Poulopoulos AK, Tsalikis L, Assimopoulou AN, Barmpalexis P (2022): A Review on Xerostomia and Its Various Management Strategies. Polymers, 14(5), 850.
📚 Rughwani V, Miao Jonasson J, Marklund B, Mossberg K, Almståhl A, Lynge Pedersen AM, Cevik-Aras H (2025): Xerostomia in primary care: a register-based study of prevalence, medication categories, and associated risk factors. Frontiers in Oral Health, 6, 1684568.

For a deeper understanding, we also recommend

← All terms starting with X← Back to the KEERN Lexicon

The KEERN Lexicon provides evidence-based educational information about oral health. It is intended to support, not replace, individual advice from a dentist, physician, or pharmacist. Diagnosis and treatment decisions should always be based on a personal clinical assessment.